← SearchADVANCED PRECLINICAL DEVELOPMENT AND PRODUCTION OF MASTER SEE VIRUS OF GEO-LM01, A NOVEL MVA-VLP VACCINE AGAINST LASSA FEVER$2,442,307FY2018Defense Health AgencyDODGeovax, Inc., Smyrna GAInvestigatorsView source on USAspending →